Shin Nippon Biomedical First-Half Net Profit More Than Doubles

Shin Nippon Biomedical Laboratories Ltd. reported net profit of ¥2.20 billion for the half-year ended Sept. 30, 2026, up from ¥1.06 billion a year earlier, under Japanese accounting standards.

November 10, 2026, 06:42 AM 300 0

Revenue rose to ¥17.57 billion from ¥14.77 billion. Operating profit increased to ¥1.56 billion, compared with ¥49.00 million in the same period of 2025, while pretax profit reached ¥3.08 billion, up from ¥1.63 billion.

Earnings per share were ¥52.79, against ¥25.48 a year earlier.

When reusing this material a link to Money Talk is required.